Ulrike M Reiss

Summary

Affiliation: St. Jude Children's Research Hospital
Country: USA

Publications

  1. ncbi Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease
    Ulrike M Reiss
    Department of Hematology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Am J Hematol 82:740-3. 2007
  2. ncbi Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child
    Scott H Maurer
    Department of Hematology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Pediatr Blood Cancer 53:468-71. 2009
  3. ncbi Severe thrombocytopenia with iron deficiency anemia
    Van K Morris
    Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
    Pediatr Hematol Oncol 27:413-9. 2010

Detail Information

Publications3

  1. ncbi Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease
    Ulrike M Reiss
    Department of Hematology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Am J Hematol 82:740-3. 2007
    ..Hydroyxurea provides a novel and useful therapeutic approach to reduce hyperviscosity from secondary erythrocytosis in patients with CCHD, while preserving oxygen carrying capacity and avoiding iron depletion by phlebotomy...
  2. ncbi Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child
    Scott H Maurer
    Department of Hematology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Pediatr Blood Cancer 53:468-71. 2009
    ..The argatroban/warfarin transition was monitored with chromogenic factor X levels. This case highlights several difficult problems in pediatric thrombosis...
  3. ncbi Severe thrombocytopenia with iron deficiency anemia
    Van K Morris
    Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
    Pediatr Hematol Oncol 27:413-9. 2010
    ..The literature exploring the mechanism behind the current clinical findings is reviewed...